zoledronic acid has been researched along with furosemide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amaddeo, P; Barbaglio, A; Faldi, F; Fontana, S; Ghilardi, R; Pericotti, S | 1 |
| Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B | 1 |
| Argüelles Jiménez, I; Carrillo García, P; García Fernández, H; Quevedo Juanals, J; Serra Soler, G | 1 |
| Avgoustidis, N; Ioakeimidis, D; Karageorgas, TP | 1 |
| Addissie, B; Kumar, R; Martens, P | 1 |
| Agarwal, A; Aung, TT; Strand, AO | 1 |
| Finazzo, F; Manzoni, P; Militello, MA; Re, MP; Vitaliti, G; Vitaliti, SM | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
2 review(s) available for zoledronic acid and furosemide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature.
Topics: Adult; Antibodies, Antinuclear; Bone Density Conservation Agents; Diphosphonates; Diuretics; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Imidazoles; Lupus Erythematosus, Systemic; Zoledronic Acid | 2011 |
12 other study(ies) available for zoledronic acid and furosemide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Male breast cancer with mandibular metastasis. A case report.
Topics: Aged; Androstadienes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cortisone; Cyclophosphamide; Diphosphonates; Docetaxel; Fatal Outcome; Fluorouracil; Furosemide; Humans; Imidazoles; Liver Neoplasms; Male; Mandibular Neoplasms; Mastectomy, Modified Radical; Methotrexate; Omeprazole; Osteolysis; Phenobarbital; Taxoids; Toremifene; Vinblastine; Vinorelbine; Zoledronic Acid | 2007 |
[Primary hyperparathyroidism. An alternative to the surgery].
Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid | 2009 |
[Parathyroid crisis due to a cystic parathyroid adenoma].
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Colectomy; Colonic Diseases; Consciousness Disorders; Cysts; Diagnostic Imaging; Diphosphonates; Emergencies; Female; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Intestinal Perforation; Kidney Calculi; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Thyroidectomy; Zoledronic Acid | 2011 |
Follicular lymphoma presenting with hypercalcaemia: an unusual mechanism of hypercalcaemia.
Topics: Aged; Bone Density Conservation Agents; Calcitonin; Chemokines; Cytokines; Diphosphonates; Diuretics; Female; Furosemide; Humans; Hypercalcemia; Imidazoles; Lymphoma, Follicular; Neoplasm Staging; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parotid Gland; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Sodium Chloride; Vitamin D; Zoledronic Acid | 2015 |
Not all ST-segment changes are myocardial injury: hypercalcaemia-induced ST-segment elevation.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Brugada Syndrome; Cardiac Conduction System Disease; Diagnosis, Differential; Diphosphonates; Diuretics; Echocardiography; Electrocardiography; Follow-Up Studies; Furosemide; Humans; Hypercalcemia; Imidazoles; Male; Multiple Myeloma; Myocardial Ischemia; Point-of-Care Testing; Treatment Outcome; Zoledronic Acid | 2015 |
Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia.
Topics: Bone Density Conservation Agents; Calcium; Drug Resistance; Fat Necrosis; Female; Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant, Newborn; Methylprednisolone; Sodium Potassium Chloride Symporter Inhibitors; Subcutaneous Fat; Term Birth; Zoledronic Acid | 2019 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |